Anal Bioanal Chem
Analytical and Bioanalytical Chemistry
1618-2642
1618-2650
Springer-Verlag
Berlin/Heidelberg


2228378
18210096
1737
10.1007/s00216-007-1737-6
Original Paper


Formation of gutingimycin: analytical investigation of trioxacarcin A-mediated alkylation of dsDNA

Fitzner
Ansgar



Frauendorf
Holm



Laatsch
Hartmut



Diederichsen
Ulf

+49-551-393221
+49-551-392944
udieder@gwdg.de



Institut für Organische und Biomolekulare Chemie, Georg-August-Universität Göttingen, Tammannstr. 2, 37077 Göttingen, Germany 

22
1
2008

2
2008

390
4
1139
1147
16
8
2007

29
10
2007

5
11
2007


© The Author(s) 2007

Formation and fragmentation of recognition complexes between trioxacarcin A and various DNA sequences were examined by temperature-dependent UV and CD spectroscopy, HPLC analysis, and ESI mass spectrometry with regard to reaction conditions, intermediates, products, mechanism, and sequence specificity. Cleavage of the trioxacarcin–DNA complexes provided the natural product gutingimycin by guanine abstraction. The resulting DNA with an abasic site was further cleaved into a DNA fragment with a furanyl unit at the 3′-end and an oligonucleotide with a phosphorylated 5′-end.

Keywords
DNA alkylation
DNA strand cleavage
Electrospray mass spectrometry
Gutingimycin
Trioxacarcin A

issue-copyright-statement
© Springer-Verlag 2008




Introduction
1
3
1
2
4
1
3
5
6
1
1
2
5
7
9
10
11
2
1
5
2
7
12
14
1
15
16
8
17
18
19
20
].
2
1
1
) and DNA fragments is described in detail.

Experimental
Methods and materials
4a
4b
5a–d
7
8
T
m
2
3
Streptomyces
6
−1
2
4
2
4
−1
2
−1
2
) in a 1:2 ratio.

UV spectroscopy
−1
2
4
2
4
−1
2
2
λ
 = 260 nm in a quartz cuvette (1 cm).

CD spectroscopy
−1
−1
2
4
2
4
−1
2
2
) (60 nmol) in 1.5 mL phosphate buffer was added and the measurement was performed in a quartz cuvette (1 cm).

Kinetic measurements
−1
2
4
2
4
−1
2
O, pH 7.0) was heated to 80 °C for 4 h. Samples of 60 μL were taken after 0, 15, 30, 45, 60, 75, 90, 120, and 240 min and analyzed by HPLC. The area under the curve of the trioxacarcin–DNA adduct peak was plotted versus time to determine the time constant as the slope of the regression line.

High-performance liquid chromatography
−1
−1
2
−1
 triethylammonium acetate buffer (80% acetonitrile and 20% water, pH 7.0).

Electrospray mass spectrometry
−1
2
4
2
4
−1
2
2
−1
m
z
m
z
 600. The capillary exit voltage was −80 V, −100 V, −140 V, or −170 V. Deconvolution and mass calculation for the corresponding ions were done using Xmass 6.1.2 from Bruker.


Results and discussion
2
4a
4b
5a–d
Fig. 1
1
2
3
)




2
4a
2
T
m
4a
T
m
2
2
2
4a
3
T
m
3
4a
2
T
m
1
Fig. 2
4a
2
−1
, 1:2)




4b
T
m
4b
2
T
m
T
m
3
2
2
1
Fig. 3
4b
2
−1
, 1:2)




4a
2
4
4a
4a
2
4a
2
Fig. 4
4a
grey
black
2
−1
dashed line
 indicates the spectrum obtained after interim heating to 90 °C




2
4a
2
5
4a
2
4a
2
4a
2
1
3
2
5
Fig. 5
4a
2
a
b
4a
 further oligonucleotides and oligonucleotide fragments are eluting between 11 and 17 min




2
4b
4a
4b
2
1
6
1
2
4a
4b
2
7
8
21
22
Fig. 6
4b
2
a
b
 after heating to 90 °C



Table 1
Examined oligomers and adduct formation

DNA oligomers
 
Adduct formula
adduct
6− a
 calcd. / found mass
adduct
6− a
 calcd. / found mass
b



AATTACGTAATT
4a

161
202
43
90
11

752.32 / 752.33
755.99 / 755.99
53

CAATTATAATTG
4b

161
202
43
90
11

752.32 / 752.39
755.99 / 756.00
10

AATTAGTAATT
5a

152
190
40
84
10

704.15 / 704.16
707.81 / 707.83
13

AATTTGAAATT
5b

152
190
40
84
10

704.15 / 704.16
707.81 / 707.82
5

AATTTGTAATT
5c

152
191
37
86
10

702.65 / 702.65
706.31 / 706.31
16

AATTAGAAATT
5d

152
189
43
82
10

705.65 / 705.66
709.31 / 709.32
1



a
 Adduct ions up to the sevenfold charged ion were observed; the relative intensities varied from oligomer to oligomer
b
 Conversion rate given by the trioxacarcin A to adduct proportion



4a
2
1
7
Fig. 7
4a
2
23
]




2
5a–d
2
5a–d
2
2
1
2
5a–d
 and results obtained by HPLC and ESI MS, adduct formation seems to be preferred when thymine is placed next to guanine with thymine neighboring the 3′-site having a greater impact. It still needs to be investigated if this result holds only for thymine in comparison with adenine or if this is a more general preference for pyrimidines over purines neighboring the trioxacarcin-substituted guanine.
6
7
T
m
6
7
2
T
m
2
2
6
7
7
8
6
2
8
Fig. 8
6
7
2
a
b
 72 h at 0 °C




2
24
30
2
5d
5d
2
9
3−
4−
5−
6−
9
m
z
1
19
20
27
31
5
m
z
6
m
z
5d
5
2−
6
T
2−
2−
31
m
z
10
4−
10
1
m
z
10
4−
10
1
10
4−
m
z
10
4−
m
z
9
Fig. 9
a
T
5d
2
b
5d
c
T
5d
2
d
5d
 adduct



Scheme 1
Proposed cleavage reaction of DNA–trioxacarcin A adduct




19
5d
2
1
1
10
8
5
9
6
9
 seems to be a perfect leaving group for generation of a furan.
5d
4a–b
5a–c
4a
4b
5a–c
5a
5d
 were the most stable.

Conclusions
2
2
) to dsDNA seems to be a prerequisite for nucleophilic attack of the guanine to form a covalent complex. Preliminary evidence indicates that trioxacarcin A-DNA interaction has sequence specificity with greater reactivity observed for guanines 5′ to thymidines. Cleavage of the trioxacarcin–DNA adducts can be initiated at higher temperatures or by applying capillary-skimmer dissociation by raising the capillary exit potential in mass spectrometry experiments leading to the formation of the bioactive secondary metabolite gutingimycin and DNA strand scission. As DNA cleavage products, a fragment with a furanyl unit at the 3′-end was identified next to an oligonucleotide with a phosphorylated 5′-end.


Acknowledgements
We are grateful for generous support of the Deutsche Forschungsgemeinschaft and of the Fonds der Chemischen Industrie.
Open Access
 This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

References
1.
Tamaoki
T

Shirahata
K

Iida
T

Tomita
F


J Antibiot
1981
34
1524
1530

Tamaoki T, Shirahata K, Iida T, Tomita F (1981) J Antibiot 34:1524–1530 

2.
Tomita
F

Tamaoki
T

Morimoto
M

Fujimoto
K


J Antibiot
1981
34
1519
1524

6895890


3.
Kayser O, Laatsch H, Maskey RP, Hansske F, Grün-Wollny I, Helmke E (2005) Trioxacarcins for use as antimicrobials, PCT Int. Appl. (01.09.2005), WO 2005080549; CA 143:225918

4.
Shirahata K, Iida T, Hirayama N (1981) Tennen Yuki Kagobutsu Toronkai Koen Yoshishu 24:199–206

5.
Maskey
RP

Sevvana
M

Usón
I

Helmke
E

Laatsch
H


Angew Chem Int Ed
2004
43
1281
1283
10.1002/anie.200352312

Maskey RP, Sevvana M, Usón I, Helmke E, Laatsch H. (2004) Angew Chem Int Ed 43:1281–1283 

6.
Maskey
RP

Helmke
E

Kayser
O

Maier
A

Fiebig
HH

Busche
A

Laatsch
H


J Antibiot
2004
57
771
779

15745111


7.
Gates
KS


DNA and aspects of molecular biology. Comprehensive natural product chemistry, vol 7
1999
New York
Elsevier
491
552

Gates KS (1999) DNA and aspects of molecular biology. Comprehensive natural product chemistry, vol 7. Elsevier, New York, pp 491–552 

8.
Hansen
MR

Hurley
LH


Acc Chem Res
1996
29
249
258
10.1021/ar950167a

Hansen MR, Hurley LH (1996) Acc Chem Res 29:249–258 

9.
Sun
D

Hansen
M

Hurley
L


J Am Chem Soc
1995
117
2430
2440
10.1021/ja00114a007

Sun D, Hansen M, Hurley L (1995) J Am Chem Soc 117:2430–2440 

10.
Maeda
K

Takeuchi
T

Nitta
K

Yagishita
K

Utahara
R

Osato
T

Ueda
M

Kondo
S

Okami
Y

Umezawa
H


J Antibiot Ser A
1956
9
75
81

Maeda K, Takeuchi T, Nitta K, Yagishita K, Utahara R, Osato T, Ueda M, Kondo S, Okami Y, Umezawa H (1956) J Antibiot Ser A 9:75–81 

11.
Hara
M

Yoshida
M

Nakano
H


Biochemistry
1990
29
10449
10455
10.1021/bi00498a003

2271655


12.
Greenberg
MM


DNA and aspects of molecular biology. Comprehensive natural product chemistry, vol 7
1999
NewYork
Elsevier
371
425

Greenberg MM (1999) DNA and aspects of molecular biology. Comprehensive natural product chemistry, vol 7. Elsevier, New York, pp 371–425 

13.
Hurley
LH


Advances in DNA sequence specific agents, vol 2
1996
Greenwich, CT
JAI Press

Hurley LH (1996) Advances in DNA sequence specific agents, vol 2. JAI Press, Greenwich, CT 

14.
Hurley
LH

Chaires
JB


Molecular aspects of anticancer drug–DNA interactions, vol 1
1993
Boca Raton, FL
CRC Press

Hurley LH, Chaires JB (1993) Molecular aspects of anticancer drug–DNA interactions, vol 1. CRC Press, Boca Raton, FL 

15.
Chan
KL

Sugiyama
H

Saito
I


Tetrahedron Lett
1991
32
7719
7722
10.1016/0040-4039(91)80574-P

Chan KL, Sugiyama H, Saito I (1991) Tetrahedron Lett 32:7719–7722 

16.
Chan
KL

Sugiyama
H

Saito
I

Hara
M


Phytochemistry
1995
40
1373
1374
10.1016/0031-9422(95)00475-M

8534399


17.
Prakash
AS

Moore
AC

Murray
V

Matias
C

McFadyen
WD

Wickham
G


Chem–Biol Interact
1995
95
17
28
10.1016/0009-2797(94)03341-2

7697748


18.
Murray
V

Moore
AC

Matias
C

Wickham
G


Biochim Biophys Acta
1995
1261
195
200

7711062


19.
Iannitti
P

Sheil
MM

Wickham
G


J Am Chem Soc
1997
119
1490
1491
10.1021/ja962439q

Iannitti P, Sheil MM, Wickham G (1997) J Am Chem Soc 119:1490–1491 

20.
Colgrave
ML

Iannitto-Tito
P

Wickham
G

Sheil
MM


Aust J Chem
2003
56
401
413
10.1071/CH02205

Colgrave ML, Iannitto-Tito P, Wickham G, Sheil MM (2003) Aust J Chem 56:401–413 

21.
Hansen
M

Hurley
L


J Am Chem Soc
1995
117
2421
2429
10.1021/ja00114a006

Hansen M, Hurley L (1995) J Am Chem Soc 117:2421–2429 

22.
Owen EA, Burley GA, Carver JA, Wickham G, Keniry MA (2002) 290:1602–1608

23.
Polster J (1995) Reaktionskinetische Auswertung spektroskopischer Messdaten. Vieweg

24.
Beck JL, Colgrave ML, Ralph SF, Sheil MM (2001) 20:61–87

25.
Huber CG, Oberacher H (2001) 20:310–343

26.
Banoub
JH

Newton
RP

Esmans
E

Ewing
DF

Mackenzie
G


Chem Rev
2005
105
1869
1915
10.1021/cr030040w

15884792


27.
Tietze
LF

Krewer
B

Frauendorf
H

Schuberth
MajorF


Angew Chem Int Ed
2006
45
6570
6574
10.1002/anie.200600935

Tietze LF, Krewer B, Frauendorf H, Major F Schuberth I (2006) Angew Chem Int Ed 45:6570–6574 

28.
Wickham
G

Iannitti
P

Boschenok
J

Sheil
MM


FEBS Let
1995
360
231
234
10.1016/0014-5793(95)00110-U

7883038


29.
Beck
JL

Colgrave
ML

Ralph
SF

Sheil
MM


Mass Spectrom Rev
2001
20
61
87
10.1002/mas.1003

11455562


30.
Iannitti-Tito
P

Weimann
A

Wickham
G

Sheil
MM


Analyst
2000
125
627
634
10.1039/a908920i

10892019


31.
McLuckey
S

Habibi-Goudarzi
S


J Am Chem Soc
1993
115
12085
12095
10.1021/ja00078a054

McLuckey S, Habibi-Goudarzi S, (1993) J Am Chem Soc 115:12085–12095 




